News

Researchers found that MYCN located on extra-chromosomal DNA enables some neuroblastoma cells to enter a dormant, therapy-resistant state. Combining chemotherapy with drugs targeting senescent cells removed aggressive and dormant cells in models.

New research has uncovered how different types of gut bacteria feed on a prominent dietary antioxidant found in mushrooms, shedding light on molecular pathways that could form a cancer drug target.

The research finds that the location of the MYCN oncogene determines whether tumor cells respond to chemotherapy or enter a state of dormancy.

Researchers have developed a blood-based diagnostic method for multiple myeloma and its precursor conditions. The method offers a non-invasive alternative to bone marrow biopsies, which are currently used to assess disease stage and genetic risk.

Scientists have developed a pH-responsive nanomaterial using graphene oxide and polyglycerol for cancer drug delivery. The nanomaterial surface changes its charge in an acidic tumor environment and enables the better uptake of drugs by cancer cells.

Study finds that preemptive genetic testing for those with two specific genes cuts chemotherapy side effects in half, as compared to similar patients given standard doses without testing.

A study led by researchers from the University of Michigan showed that targeting CDK12 and a related gene, CDK13, strongly activates the stimulator of interferon genes, or STING, signaling pathway, enhancing the effectiveness of immunotherapies.

Researchers have developed an imaging method called oxygen-enhanced endoscopy to detect cancerous lesions in the esophagus with high precision.

Researchers have developed a new single-atom-thick carbon material that could revolutionise proton therapy for cancer patients, and advance technologies in medicine and other areas such as energy devices and flexible electronics.

Researchers have found a critical link between having two types of polyps, common growths found in the bowel, and an increased risk of developing cancer.